OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Transgene Biotek OCF Yield % Related Terms
Transgene Biotek OCF Yield % Historical Data
* Premium members only.
The historical data trend for Transgene Biotek's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526139 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Transgene Biotek's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transgene Biotek OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Transgene Biotek's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Transgene Biotek's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Transgene Biotek (BOM:526139) has a OCF Yield % of -0.05 as of Jul. 13, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Transgene Biotek and its competitors. According to the industry distribution chart, Transgene Biotek ranks #302 out of 1410 companies in the Biotechnology industry, placing it in the top 21.4%.
Is Transgene Biotek's OCF Yield % too high?
Transgene Biotek's current OCF Yield % is -0.05. Based on the distribution chart, Transgene Biotek ranks #302 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Transgene Biotek has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Transgene Biotek's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Transgene Biotek ranks #302 out of 1410 companies for OCF Yield %. This places Transgene Biotek in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Transgene Biotek and its competitors. Transgene Biotek's current OCF Yield % is -0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgene Biotek stock overvalued right now?
Based on GuruFocus' analysis, Transgene Biotek (BOM:526139) is currently considered Possible Value Trap. The stock's GF Value™ is ₹6.57, compared to a current price of ₹3.08 — trading 53.1% below its estimated fair value. The current OCF Yield % is -0.05. Transgene Biotek's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Transgene Biotek (BOM:526139), the current OCF Yield % is -0.05 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Transgene Biotek (BOM:526139) Overvalued in 2026?
Based on GuruFocus' analysis, Transgene Biotek stock appears to be undervalued.
The current stock price of ₹3.08 is trading 53.1% below its estimated GF Value™ of ₹6.57.
GuruFocus considers Transgene Biotek to be Possible Value Trap.
Key valuation signals for BOM:526139:
OCF Yield %: -0.05
GF Value™: ₹6.57 vs. price of ₹3.08 (53.1% below fair value)
No single metric tells the full story. See the BOM:526139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.
57GF Score
Get the complete analysis for BOM:526139
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526139 has been successfully added to your 
